ArticleFrontiers in cardiovascular medicine2026
Blood urea nitrogen-to-serum albumin ratio as a predictor of long-term mortality in patients with acute heart failure.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The objective of this study was to evaluate the baseline blood urea nitrogen-to-serum albumin ratio (BAR) in patients with acute heart failure (AHF) upon admission as a predictor of long-term mortality. Methods: In this retrospective cohort study, a total of 2,556 patients who were hospitalized for AHF at Beijing Anzhen Hospital between 2017 October and 2020 January were enrolled. Multivariate Cox regression analysis was performed to explore the association between BAR and out-of-hospital all-cause mortality. The risk stratification capability of BAR was also calculated using Kaplan-Meier survival analysis. Results: Of the 2,556 patients with AHF, 1,196 had with heart failure with reduced ejection fraction, 1,066 had heart failure with preserved ejection fraction, and 294 had heart failure with mildly reduced ejection fraction. After a median follow-up of 1.84 years (IQR: 1.15, 2.57), 665 (26.0%) patients experienced out-of-hospital all-cause mortality. Univariate Cox regression analysis revealed that BAR was significantly associated with long-term mortality in all patients with AHF ( Conclusion: BAR was associated with long-term mortality in patients with AHF after discharge, regardless of left ventricular ejection fraction at admission. BAR exhibited risk stratification capacity for long-term mortality outcomes in patients with AHF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.